Translational control of microglial inflammatory and neurodegenerative responses

Sara Bermudez,Jung-Hyun Choi,Jacob W. Vogel,Sung-Hoon Kim,Niaz Mahmood,Vivian Yuchan Zhu,Danielle Cozachenco,Moein Yaqubi,Linqiao Zhou,Jo Ann Stratton,Oskar Hansson,Luke Healy,Argel Aguilar-Valles,Nahum Sonenberg

DOI: https://doi.org/10.1101/2024.04.06.587750

2024-04-09

Abstract:In Alzheimer’s Disease (AD), activation of the mechanistic target of rapamycin (mTOR) pathway is essential for microglia neuroprotective roles, but it is unclear which mTOR effectors promote these neuroprotective functions. The mTOR complex 1 (mTORC1) inactivates the translation suppressors eukaryotic translation Initiation Factor 4E (eIF4E)-Binding Proteins (4E-BP) to promote mRNA translation. We show that 4E-BP1 inactivation is impaired in microglia under AD-relevant conditions. Depleting 4E-BPs in microglia increases mitochondrial metabolism, suppresses the pro-inflammatory profile, and mitigates amyloid-induced apoptosis. Furthermore, in the cerebrospinal fluid of patients with amyloid pathology, there was a positive association between microglia activation and neurodegeneration, which increases along 4E-BP1 levels. Thus, we propose the engagement mTORC1-4E-BP1 axis as a neuroprotective mechanism and a therapeutic target or biomarker for microglia modulation in AD.

Neuroscience